Farmas USA

AVEO ficha como Chief Financial Officer al que lo era de SNTA....

"... The company believes the data support its planned Phase 2 clinical trials of TH-4000 ..."

Otro estudio que tira pa'lante :)

"... treatment with TH-4000, resulted in 9/9 complete responses, suggesting an ability to prevent or overcome resistance to TKI treatment. ..."

THLD

NAVB

Navidea Biopharma (NAVB) Issues Encouraging Update on Manocept in TAMs, KS Tumor Cells

http://www.streetinsider.com/Corporate+News/Navidea+Biopharma+%28NAVB%29+Issues+Encouraging+Update+on+Manocept+in+TAMs%2C+KS+Tumor+Cells/10478968.html?si_client=intbro

ONVO

Organovo (ONVO) Enters Multi-Year Research Collaboration Agreement with Merck (MRK)

http://www.streetinsider.com/Corporate+News/Organovo+%28ONVO%29+Enters+Multi-Year+Research+Collaboration+Agreement+with+Merck+%28MRK%29/10478936.html

ENZN para corazones fuertes

Vaya PRE de AMRN
rango de 2,55-2,29 con 2900 cromos

NVAX. Cerrado gap de apertura, ale pa'rriba 

THLD

El Viernes es la reunion de inversores y analistas